Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program

By sjmartinez • January 23, 2024

Kanise H, van Oosterhout JJ, Bisani P, Songo J, Matola BW, Chipungu C, Simon K, Cox C, Hosseinipour MC, Sagno JB, Hoffman RM, Wallrauch C, Phiri S, Steegen K, Jahn A, Nyirenda R, Heller T. Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program. Viruses. 2023 Dec 23;16(1):29. doi: 10.3390/v16010029. PMID: 38257730.

Tags: antiretroviral therapy, dolutegravir, Drug resistance, HIV, Infectious Diseases, Malawi, mutations, Outcomes, Publications

Efficacy assessments of EL219, a next-generation polyene antifungal, in immunosuppressed mice infected with drug-sensitive and drug-resistant Aspergillus isolates

Youssef EG, Gebremariam T, Gu Y, Patterson H, Alkhazraji S, Elsayed T, Wiederhold NP, Ibrahim AS. Efficacy assessments of EL219, a next-generation polyene antifungal, in[...]

Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship

Paras ML, Stead W, Bisono-Garcia B, Pottinger PS, Aziz R, Aziz M, Balba GP, Blackburn BG, Butt S, Chow B, Graber CJ, Muñoz-Gomez S, Pellegrino[...]

Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness

Tewari SE, Hoffman R, Lockman S, Flanagan CF, Webb KA, Horsfall S, Chimwaza A, Dugdale CM, Currier J, Dhodho E, Neilan AM, Masiye K, Rana[...]